Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > big events are approaching
View:
Post by Charly50 on Apr 12, 2022 11:46am

big events are approaching

 Bio, stop whining. Treat yourself to a break and book a sailing boat trip with Metalle. dr Anke Schulthe from Bayer, formerly Sanofi, will give you mineral water. Frank and PT drink champagne and toast to big events: Upcoming events Event - April 20, 2022 Cell & Gene Meeting on the Med Event - April 28, 2022 Sernova Virtual Annual General Meeting (AGM) Event - May 02, 2022 2022 Bloom Burton & Co Healthcare Investor Conference Event - May 17, 2022 Roth Canada Corporate Access Day Event - May 23, 2022 H.C. Wainwright Global Life Sciences Conference Event - May 24, 2022 Oppenheimer MedTech Summit Event - June 13, 2022 BIO International Convention Event - June 28, 2022 A Truist Securities Cell Therapy Symposium
Comment by BioTeck on Apr 12, 2022 11:59am
Oh look who's back, it's the german fluff doll fraulein with a fluffy update of conferences. The only thing this fluff means is flights and hotels and expensive wine for Selphie and for shareholders to pickup the tab. I present links to videos and facts and the company schills have nothing to respond except for stop whining. Even the stache riders are running out of steam.
Comment by BioTeck on Apr 12, 2022 12:05pm
I wouldn't be too excited about a 15 minute presentation. That is just about enough time for Chucky or DummyMouth to enjoy uncle Frankies lip caterpillar. 
Comment by Charly50 on Apr 12, 2022 12:15pm
Don't shoot from the hip too quickly. Just wait and see what happens and then judge. Please not the other way around, young man.
Comment by Metalsguy1 on Apr 12, 2022 3:16pm
Fraulein you must be the absolute dumbest person in Germany. The meeting and presentation are small potatoes but not as small as your pea brain. The evidence of your ignorance goes back to last summer when you predicted an imminent rise in the stock prize but certainly not your I Q. Why don't you just go back to cruising the autobahn for a quick whack in the weeds.
Comment by Charly50 on Apr 12, 2022 12:38pm
Bio, luckily intelligence is not a question of nationality. I think they're hurting themselves the most!
Comment by Metalsguy1 on Apr 12, 2022 3:11pm
our favorite putzfrau is back but doesn't know how to use a keyboard anymore and since she has mentioned me by name I will assume she is missing the abuse.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities